Skip to main content
. 2023 Aug 18;16(8):1293–1298. doi: 10.18240/ijo.2023.08.16

Table 1. Details of 13 patients with orbital liposarcoma.

No. Age (y) Sex Affected orbital side Disease course (mo) Disease status Clinical manifestations Visual acuity Operative treatment Follow-up treatment Relations between liposarcoma with surrounding tissue Longest diameter of liposarcoma (cm) Histological subtype Immunohistochemical indicators
Ki-67 Vimentin CD34 SMA S-100
1 51 F OS 1 Primary Eyelid palpable mass 1 Tumor resection Radioactive seed implantation Orbital bone 1.8 Myxiod 60%
2 44 M OD 16 Primary Eyelid palpable mass 5.1 Orbital exenteration External gamma radiation therapy Optic nerve 6 Dedifferentiated 1%
3 81 M OS 12 Primary Proptosis & diplopia 4.9 Tumor resection Radioactive seed implantation 2.8 Myxiod
4 36 F OD 2 Primary Proptosis 4.85 Tumor resection External gamma radiation therapy 5 Pleomorphic 70%
5 61 F OS 10 Primary Proptosis & epiphora 4.9 Tumor resection External gamma radiation therapy 2.8 Well-differentiated 1%
6 19 F OD 12 Primary Proptosis 5 Tumor resection Striated muscle Myxiod 3%
7 24 F OD 36 Primary Proptosis 4.8 Tumor resection No follow-up treatment Striated muscle Dedifferentiated 100%
8 63 M OS 12 Primary Proptosis 4.7 Orbital exenteration No follow-up treatment Optic nerve 3.5 Myxiod 5%
9 36 F OD 9 Primary Proptosis 3.8 Orbital exenteration External gamma radiation therapy Optic nerve 4 Well-differentiated 5%
10 57 F OD 24 Primary Proptosis & diplopia 3 Tumor resection No follow-up treatment Striated muscle 2 Dedifferentiated 3%
11 34 M OD 1 Primary Proptosis 4.85 Tumor resection External gamma radiation therapy Orbital bone 4 Myxiod 40%
12 50 M OS 8 Secondary Proptosis 3.5 Tumor resection Striated muscle Myxiod
13 32 F OD 6 Primary Proptosis 3.3 Tumor resection External gamma radiation therapy Striated muscle 3.5 Well-differentiated 20%

OD: Right eye; OS: Left eye; SMA: Smooth muscle actin.